Alexion Pharmaceuticals Investor Relations Material
Latest events
Q4 2020
8 Feb, 2021
Q4 2019
4 Feb, 2020
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Alexion Pharmaceuticals Inc
Access all reports
Alexion Pharmaceuticals Inc focused on the development and commercialization of therapies for rare diseases. The company specialized in biologics targeting immune-mediated rare conditions and offered treatments across neurology, hematology, nephrology, and metabolic disorders. Alexion operated globally through research, manufacturing, and commercial networks. The company was headquartered in Boston, Massachusetts, and its shares were listed on the NASDAQ.
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
ALXN
Country
🇺🇸 United States